{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:48:25Z","timestamp":1789645705099,"version":"4.0.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anaerobe.2021.102378","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T22:55:47Z","timestamp":1620341747000},"page":"102378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Three is a crowd: Clinical outcomes of a twice daily versus a thrice daily metronidazole dosing strategy from a multicenter study"],"prefix":"10.1016","volume":"71","author":[{"given":"Sunish","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8665-4544","authenticated-orcid":false,"given":"Jacob","family":"Merwede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Topal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2021.102378_bib1","doi-asserted-by":"crossref","unstructured":"Shinn, D. Metronidazole in acute ulcerative gingivitis. Lancet 279, 1191.","DOI":"10.1016\/S0140-6736(62)92243-2"},{"issue":"2","key":"10.1016\/j.anaerobe.2021.102378_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/pharmacy6020043","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice","volume":"6","author":"Fuentes","year":"2018","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.anaerobe.2021.102378_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","article-title":"Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms","volume":"73","author":"Dingsdag","year":"2018","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.anaerobe.2021.102378_bib4","first-page":"57","article-title":"Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infections","volume":"5","author":"Soule","year":"2018","journal-title":"Ther Adv Infect Dis"},{"issue":"4","key":"10.1016\/j.anaerobe.2021.102378_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jac\/23.4.619","article-title":"Twelve-hourly dosage schedule for oral and intravenous metronidazole","volume":"23","author":"Earl","year":"1989","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2021.102378_bib6","series-title":"Metronidazole [package Insert]","year":"2003"},{"key":"10.1016\/j.anaerobe.2021.102378_bib7","series-title":"R: a Language and Environment for Statistical Computing","year":"2016"},{"issue":"3","key":"10.1016\/j.anaerobe.2021.102378_bib8","first-page":"57","article-title":"Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infections","volume":"5","author":"Soule","year":"2018","journal-title":"Ther Adv Infect Dis"},{"issue":"11","key":"10.1016\/j.anaerobe.2021.102378_bib9","first-page":"1167","article-title":"Metronidazole cost containment: a two-stage intervention","volume":"25","author":"Bunz","year":"1990","journal-title":"Hosp. Formul."},{"key":"10.1016\/j.anaerobe.2021.102378_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anaerobe.2019.04.002","article-title":"Antimicrobial susceptibilities of clinical isolates of the anaerobic bacteria which can cause aspiration pneumonia","volume":"57","author":"Fujita","year":"2019","journal-title":"Anaerobe"},{"issue":"4","key":"10.1016\/j.anaerobe.2021.102378_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/47.4.421","article-title":"The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients","volume":"47","author":"Joynt","year":"2001","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"6093","key":"10.1016\/j.anaerobe.2021.102378_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.2.6093.991","article-title":"Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole","volume":"2","author":"Ingham","year":"1977","journal-title":"Br. Med. J."},{"issue":"5","key":"10.1016\/j.anaerobe.2021.102378_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/clinids\/17.5.857","article-title":"Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients","volume":"17","author":"Sj\u00f6lin","year":"1993","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.anaerobe.2021.102378_bib14","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J.\u00a0Clin. Microbiol."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996421000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996421000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:40:14Z","timestamp":1761036014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996421000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":14,"alternative-id":["S1075996421000615"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2021.102378","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three is a crowd: Clinical outcomes of a twice daily versus a thrice daily metronidazole dosing strategy from a multicenter study","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2021.102378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102378"}}